Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Check source scope before reading a dose
Escitalopram tablets (adults) - selected U.S. labeling
Product / population
Adult major depressive disorder and generalized anxiety disorder; oral escitalopram tablets. Pediatric and oral-solution dosing are outside this summary.
Renal method
CrCl in mL/min for the below-20 data boundary; no severe-renal dose algorithm.
Source revision
Label revision date not separately recorded; retrieval date is not the revision date.
Retrieved
2026-09-05
Local review status
Selected dosing/renal sections read; concise local summary, not full prescribing information.
Official
Escitalopram tablets (adults) - selected U.S. labeling
U.S. product labeling / DailyMed · Adult major depressive disorder and generalized anxiety disorder; oral escitalopram tablets. Pediatric and oral-solution dosing are outside this summary.
Renal method: CrCl in mL/min for the below-20 data boundary; no severe-renal dose algorithm. Source date: Label revision date not separately recorded; retrieval date is not the revision date. Retrieved: 2026-09-05
Selected dosing/renal sections read; concise local summary, not full prescribing information.
Labeled basic dosing
The adult starting/recommended dose is 10 mg orally once daily. Based on response and tolerability, increase no sooner than one week to a maximum 20 mg/day. Most older adults and patients with hepatic impairment use 10 mg/day.
No change is needed for mild or moderate renal impairment. At adult CrCl below 20 mL/min, a recommended dosage has not been determined. A dialysis-specific regimen is not supplied.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.